Clinical Trials Browser

Colonic Neoplasms, Colorectal Neoplasms

NCT03391934 2023-04-05

Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer

Phase 3 Unknown

234 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05766605 2023-03-13

Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Phase 3 Unknown

90 enrolled

Gastrointestinal

Hepatocellular Carcinoma Resectable

NCT05701436 2023-03-02

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Phase 3 Unknown

144 enrolled

Liver, Cancer of, Primary Resectable

NCT05231382 2022-05-24

Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma

Phase 3 Unknown

426 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT01150045 2022-03-22

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

Phase 3 Unknown

2,527 enrolled 14 charts

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT02934464 2021-09-13

ARMANI

Phase 3 Unknown

280 enrolled

Gastrointestinal

Stomach Neoplasms

NCT04961970 2021-07-14

HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC

Phase 3 Unknown

188 enrolled

Gastrointestinal

Cholangiocarcinoma

NCT03771846 2019-12-05

HAIC Versus Systemic Chemotherapy for Unresectable ICC

Phase 3 Unknown

188 enrolled

Gastrointestinal

Cholangiocarcinoma

NCT03522649 2019-06-18

A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer

Phase 3 Unknown

668 enrolled

Gastrointestinal

Previously Treated Metastatic Colorectal Cancer

NCT02965248 2018-06-19

Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)

Phase 3 Unknown

147 enrolled

Gastrointestinal

Locally Advanced Colorectal Cancer

NCT03468231 2018-03-16

HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC

Phase 3 Unknown

300 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT03303495 2017-10-06

A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC

Phase 3 Unknown

280 enrolled

Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT01308086 2017-08-09

Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer

Phase 3 Unknown

2,000 enrolled

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT03192618 2017-06-20

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Phase 3 Unknown

290 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT03192644 2017-06-20

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Phase 3 Unknown

162 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT02506842 2016-08-11

Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection

Phase 3 Unknown

300 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02785146 2016-06-08

Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer

Phase 3 Unknown

230 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02500940 2015-07-17

Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

54 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02402972 2015-03-31

A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer

Phase 3 Unknown

700 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01941979 2014-10-30

A Study Comparing Adjuvant Chemotherapy Versus Observation for Patients With Rectal Adenocarcinoma After Neoadjuvant Chemo-Radiotherapy Treatment.

Phase 3 Unknown

309 enrolled

Gastrointestinal

Rectal Neoplasms

NCT01586611 2014-10-02

Panc001

Phase 3 Unknown

175 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT00433927 2014-03-14

5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)

Phase 3 Unknown

568 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00008281 2014-01-06

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00002692 2013-12-19

Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Phase 3 Unknown

312 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00002893 2013-12-19

Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Phase 3 Unknown

900 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00021281 2013-12-19

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00002896 2013-09-20

Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer

Phase 3 Unknown

774 enrolled

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT00003063 2013-09-20

Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer

Phase 3 Unknown

1,050 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00002793 2013-09-17

Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer

Phase 3 Unknown

336 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00003558 2013-08-07

Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin

Phase 3 Unknown

140 enrolled

Tumor-Agnostic

Neoplasms, Unknown Primary

NCT00482222 2013-01-23

Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer

Phase 3 Unknown

340 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00006479 2011-04-18

Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Phase 3 Unknown

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00209742 2010-05-26

Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer

Phase 3 Unknown

340 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00764907 2009-07-08

Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

Phase 3 Unknown

4,000 enrolled

Other hematologic neoplasm

Leukemia

NCT00091312 2009-02-09

Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

Phase 3 Unknown

1,976 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00003260 2009-01-13

Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer

Phase 3 Unknown

109 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00006468 2009-01-13

Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00337389 2007-11-19

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Phase 3 Unknown

1,200 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Clinical Trials

IDEA

Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer

Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

ARMANI

HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC

HAIC Versus Systemic Chemotherapy for Unresectable ICC

A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer

Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)

HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC

A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC

Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection

Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer

Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma

A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer

A Study Comparing Adjuvant Chemotherapy Versus Observation for Patients With Rectal Adenocarcinoma After Neoadjuvant Chemo-Radiotherapy Treatment.

Panc001

5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer

Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer

Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer

Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin

Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer

Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer

Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer

Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.